Does prednisolone cause mydriasis (iris dilation)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Prednisolone Cause Mydriasis (Iris Dilation)?

Yes, prednisolone can occasionally cause mydriasis (pupil dilation), though this is not a common or primary effect of the medication.

Direct Evidence from FDA Labeling

The FDA drug label for ophthalmic prednisolone explicitly lists mydriasis as an adverse reaction that has been "occasionally reported following local use of corticosteroids" 1. This establishes that pupil dilation can occur with prednisolone use, though the term "occasionally" indicates it is not a frequent occurrence 1.

Mechanism and Clinical Context

Prednisolone acetate functions primarily as a glucocorticoid with anti-inflammatory properties, inhibiting edema, capillary dilation, and inflammatory responses 1. Mydriasis is not part of its intended pharmacologic mechanism—it occurs as an adverse effect rather than a therapeutic action 1.

Key Clinical Considerations:

  • Prednisolone does NOT actively dilate pupils in the way that anticholinergic agents (cyclopentolate, tropicamide) or sympathomimetic agents (phenylephrine) do 2

  • When mydriasis occurs with prednisolone, it represents an adverse reaction rather than expected pharmacology 1

  • In surgical contexts, prednisolone has been studied for its ability to maintain mydriasis (prevent miosis) during cataract surgery, not to induce dilation 3, 4

Evidence from Surgical Studies

Research examining preoperative prednisolone use shows:

  • Prednisolone can help maintain intraoperative mydriasis when pupils are already dilated with standard mydriatic agents 3

  • However, one study found prednisolone failed to maintain mydriasis at crucial surgical steps when compared to placebo 4

  • Prednisolone's role is preventing pupillary constriction during inflammation, not causing active dilation 3

Clinical Pitfalls to Avoid

  • Do not rely on prednisolone as a mydriatic agent for procedures requiring pupil dilation 2

  • In patients with narrow angles or primary angle-closure disease, be aware that any medication causing mydriasis (even occasionally) could theoretically precipitate angle closure, though this is not a commonly reported concern with prednisolone 5

  • The other adverse ocular effects of prednisolone (elevated IOP, cataract formation, delayed wound healing) are far more clinically significant than mydriasis 1

In summary: while prednisolone can occasionally cause mydriasis as an adverse effect, this is uncommon and should not be considered a primary or predictable action of the medication.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.